Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse MRP8 ELISA Kit (AC3393)
Cat.#: ASET-1982
Specifications
Description Mouse MRP8 ELISA Kit allows for the in vitro quantitative determination of mouse MRP8 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.375 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.625-40 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2056 Bovine Insulin ELISA Kit (AC3467) Quantitative inquiry ASET-1339 Human YWHAE ELISA Kit (AC2750) Quantitative inquiry ASET-2246 Human NT-4 ELISA Kit (AC3657) Quantitative inquiry ASET-1571 Human VCAM1 ELISA Kit (AC2982) Quantitative inquiry ASET-1539 Rabbit Estradiol ELISA Kit (AC2950) Quantitative inquiry ASET-2266 Human beta 1 Adrenergic Receptor ELISA Kit (AC3677) Quantitative inquiry ASET-1908 Mouse NCAM1 ELISA Kit (AC3319) Quantitative inquiry ASET-1258 Human PCDH1 ELISA Kit (AC2669) Quantitative inquiry ASET-2510 Mouse beta 1 Adrenergic Receptor ELISA Kit (AC3921) Quantitative inquiry ASET-1022 Human Neurexin 1 ELISA Kit (AC2433) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket